Incyte: Our Commitment to Inclusion
Incyte is a global biopharmaceutical company that seeks to develop and bring to market treatments for people living with diseases where there are unmet needs. In order to best serve our patients, we are focused on fostering a collaborative, innovative and inclusive culture that is rooted in diverse abilities, experiences, perspectives and backgrounds.
Inclusion in the Workplace
We’re proud of the inclusive and collaborative environment we have created where every individual can contribute to their full potential.
We take the time to speak directly to our employees about their needs and experiences, and we are committed to providing competitive, equitable compensation and comprehensive benefits to empower every Incyte employee to thrive at work and at home.
We continuously evaluate our efforts to ensure every employee feels they can contribute to their fullest potential across our organization.
Our goal is to ensure that our commitment and actions toward an inclusive culture are clear to our employees, those we do business with and the patients we serve. These corporate objectives are tied to measurable success as part of our Environmental, Social and Governance frameworks.
Global Headquarters
To track our progress in the U.S., where approximately 50 percent of our workforce is located, we launched an employee feedback tool and established an Inclusion Committee comprised of a diverse team of 50 U.S.-based employees to identify areas of improvement and implement initiatives that will enable us to reach our goals. We created five key subcommittees with clear and measurable objectives:
Identify sources of recruitment for diverse candidates
Focus on developing and retaining our diverse employees
Develop resources and programs to support our inclusive culture and raise awareness of U.S. Inclusion Committee initiatives
Explore opportunities to increase the inclusion of diverse patients in our clinical trials
Broaden partnerships to include more diverse consultants, agencies, firms, and suppliers
Best-In-Class Workplace
Our teams garnered several honors recognizing the innovation and collaboration behind our best-in-class workplaces around the world. Since 2018, Incyte has been recognized as a top five employer in the global biotechnology and pharmaceutical industry by Science Magazine and has been included in Newsweek’s Most Loved Workplace lists since 2022.
Ranked #2 among 2023 Top Employers by Science Magazine
Ranked #21 among 2023 Global Top 100 Most Loved Workplaces by Newsweek
Ranked #23 among 2023 America’s Top 100 Most Loved Workplaces by Newsweek
Received 4.5-star rating among 2024 America’s Greatest Workplaces for Diversity by Newsweek
I am proud to work for a company that fosters a vibrant culture of inclusion. At Incyte, diverse ideas and perspectives truly matter and collaboration across the organization is the cornerstone of our success.
Derek Hall, Director, Clinical QA
Working at Incyte and having the opportunity to lead a clinical development program of multiple assets has been one of the most fulfilling experiences of my career. The individuals I work with on a day-to-day basis are some of the most intelligent, caring, and driven people, and they make coming to work every day an absolute pleasure.
Abhishek D., Associate Vice President, Global Program Head – GVHD
#TeamIncyte Celebrates Diversity
Incyte Inclusion in Clinical Trials
Representing diverse communities within our clinical trials is essential for understanding and treating disease—the more diverse the participants, the more our researchers can learn about the different ways in which people respond to treatments.
Because studies have shown that minorities and people from historically marginalized groups in the U.S. are less likely to be included in clinical research, we’ve made it a priority to remove participation barriers and increase racial and ethnic diversity in our clinical trials.
To advance this mission, a sub-committee of our Inclusion Team focused on clinical trials created a new iDIRECT (Incyte Diversity, Inclusion, Representation and Equity in Clinical Trials) team dedicated to promoting diversity in clinical trials. The iDIRECT team identified strengths and opportunities for improving diversity in our current clinical trials and suggested strategies to enhance diverse participation in future trials.
These insights informed our new Clinical Trial Diversity Roadmap. Guided by the Roadmap, we’ve established a standard approach to determining diversity enrollment goals, launched a dashboard detailing diversity enrollment metrics for U.S. clinical studies, and leveraged real world evidence to identify sites that can enroll diverse patients and invite them to participate in our studies.